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PFAPA syndrome is not a sporadic disease
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Abstract
Objectives. To determine whether PFAPA (periodic fever, aphthous stomatitis, pharyngitis and cervical
adenitis) patients have a positive family history (FH) for recurrent fever syndromes.
Method. For all patients with PFAPA seen in two paediatric rheumatology centres (Romandy, Switzerland
and Bordeaux, France), parents were interviewed to record the FH for periodic fever. As controls, we
interviewed a group of children without history of recurrent fever.
Results. We recruited 84 patients with PFAPA and 47 healthy children. The FH for recurrent fever (without
an infectious cause and recurring for at least half a year) was positive in 38/84 (45%), and was positive for
PFAPA (diagnosis confirmed by a physician) in 10/84 (12%) of the PFAPA patients. For 29 of the
38 patients with positive FH, the affected person was a sibling or a parent. None of the healthy children
had a positive FH for recurrent fever or PFAPA. A positive FH for rheumatological diseases was seen in
both groups of children.
Conclusion. These data show that a significant percentage of PFAPA patients present a positive FH of
recurrent fever and PFAPA. This familial susceptibility suggests a potential genetic origin for this
syndrome.
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Introduction
PFAPA syndrome (periodic fever, aphthous stomatitis,
pharyngitis and cervical adenitis) is a recurrent febrile dis-
ease first described in 1987 by Marshall et al. [1]. It is
characterized by fever episodes, lasting for 3–6 days
with a recurrence every 3–8 weeks, and accompanied
by aphthous stomatitis, pharyngitis or cervical adenitis
[2]. No specific diagnostic test for PFAPA is available
and the diagnosis is based on published diagnostic cri-
teria [2, 3]. The patient should not present any upper re-
spiratory tract infection, must be totally asymptomatic
between the episodes and present normal growth and
development. Various febrile diseases should be
excluded, like recurrent infections, immunodeficiency,
Still’s disease, haematological diseases and monogenic
auto-inflammatory diseases [3].
Since the first description of PFAPA, no clear aetiology
has been found and it is considered a sporadic disease
[3–5]. The exact prevalence of this syndrome is not known
but PFAPA seems to be far more frequent than other
auto-inflammatory diseases [2, 3].
To better understand PFAPA syndrome, in 2007 we es-
tablished a European registry with the participation of
8 countries and 14 rheumatological centres [6]. A prelim-
inary analysis of the data showed a surprisingly high
number of patients with a positive family history (FH) for
recurrent fever. Based on this observation, we decided to
investigate more precisely the FH of PFAPA patients in
order to determine whether there is a familial predomin-
ance in this syndrome.
Patients and methods
From centres participating in the European PFAPA regis-
try, we included all patients from Romandy (n= 46) and
Bordeaux (n= 39). The patients were diagnosed accord-
ing to previously published diagnostic criteria [2, 3].
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All patients had recurring fever episodes with a median
maximum temperature of 40C, and at least one of the
cardinal symptoms (pharyngitis, cervical adenitis and
oral aphthosis); 35/84 presented all three symptoms. All
patients were in a good general condition between the
fever attacks and they showed normal growth and devel-
opment. Monogenic auto-inflammatory diseases were
excluded by clinical presentation, completed by labora-
tory tests if necessary. Genetic testing for common peri-
odic fevers was performed by DNA sequencing of the
most clinically relevant exons.
All parents were asked for the FH of the patient during a
5- to 10-min phone interview. Questions were asked fol-
lowing a questionnaire with a list of items: FH for recurrent
fever (without an infectious cause and recurring for at least
half a year), PFAPA syndrome (diagnosis confirmed by
a physician), chronic inflammatory rheumatological dis-
eases and psoriasis. When a question was answered
positively, we asked for the family rank of the affected
person and if the diagnosis was confirmed by a physician.
We performed the same interview on children without a
history of recurrent febrile attacks or chronic disease and
who attended the consultation of one of the three paedia-
tricians participating in the study. These children were
randomly selected among those consulting for regular
control of their development or an acute illness. The
study was approved by our local ethics committee
(Commission d’E´thique de la Recherche Clinique du
CHUV) and the parents gave their informed consent for
the study.
Statistical methods
Analyses were conducted using STATA 10.1 (Stata Corp.,
College Station, TX, USA). To examine bivariate associ-
ations between two variables, we used Fisher’s exact test
when the two variables were categorical, and a
non-parametric Wilcoxon test if one was continuous and
the second was categorical. The difference between
FH-positive (FH+) and FH-negative (FH) patients was
analysed using logistic regression. Significant bivariate
predictors (P< 0.1) were included in a multivariate logistic
regression.
Results
We were able to contact the parents of 84 out of our
85 PFAPA patients and all agreed to answer the ques-
tions. The mean age at the time of the interview was
7.5 years (2–25 years) with a girl to boy ratio of 1 : 1.4 for
the PFAPA patients; 6.9 years (4–13 years) and 1 : 1.35 for
the 47 healthy children. Monogenic auto-inflammatory
diseases were excluded by the clinical presentation
in 64 patients and by genetic testing in 20 patients
[Tumor necrosis factor receptor-associated periodic syn-
drome (TRAPS): 12; FMF: 14; HyperIgD syndrome: 3;
Cryopyrin-associated periodic syndrome: 1].
A positive FH for recurrent fever was found in 38/84
(45%) of the PFAPA patients. In 29/38 (76%) of the pa-
tients, the affected family member was a sibling or parent.
In 10/38 (26%) patients, the recurrent fever syndrome in
the family member was diagnosed as PFAPA by a phys-
ician. In 3/38 (8%) patients a FMF was reported, and in 2
of them the father was affected and the PFAPA patient
was heterozygous for M694V. In one of the patients with
positive FH for FMF, the affected father and uncle were
followed in childhood by the same paediatric rheumatolo-
gist, and the diagnosis was confirmed by genetic testing.
In 25/38 (66%), the affected family member reported re-
current fever without an established diagnosis. Seven
PFAPA patients had two family members with recurrent
fever (PFAPA: one, FMF: two, recurrent fever: four).
Among the 64 patients with PFAPA diagnosed by clinical
presentation, the percentage of FH+ 26/64 (41%) was
lower than in the group of patients who had genetic test-
ing, 12/20 (60%).
In the group of healthy children, the FH was com-
pletely negative for recurrent fever and PFAPA. A positive
FH for rheumatological diseases (RA: 8; seronegative arth-
ritis: 11; rhizomelic pseudopolyarthritis: 1; lupus: 2; scler-
oderma: 1; Hashimoto: 1) was found more frequently in
the PFAPA patients [19/84 (23%)] than in the healthy chil-
dren group [5/47 (11%)] (cf. Fig. 1), but the difference was
not statistically significant. Psoriasis was found in equal
proportion in both groups of children.
We analysed the origin of the parents of the FH+ and FH
patients and the healthy children: for the majority both par-
ents originated from the country of living (France or
Switzerland) in the three groups of children. We then eval-
uated whether FH+ and FH patients could correspond to
two distinct subsets of PFAPA (Fig. 2). Bivariate logistic
regression did not show any significant difference in the
age of onset, symptom duration, sex ratio, maximal
FIG. 1 Percentage of children with positive FH for PFAPA,
recurrent fever and rheumatological diseases in PFAPA
patients and in healthy children.
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temperature during the fever episodes or presenting
symptoms except for headache [Odds Ratio (OR) = 2.54,
P= 0.076], abdominal pain (OR = 3.38, P= 0.011) and
vomiting (OR = 3.46, P= 0.089). In the multivariate analysis,
only abdominal pain was still significantly associated with
FH+. The frequency of the complete PFAPA cluster (pres-
ence of all three main clinical symptoms: pharyngitis, cer-
vical adenitis and aphthous stomatitis) was similar in FH+
(44.1%) and in FH (42.2%) patients.
Discussion
With this study, we show that nearly half of our PFAPA
patients have a positive FH for recurrent fever. Most of
these family members reported a recurrent fever of un-
known origin similar in clinical presentation to the affected
child, but in 10 patients the family member had an estab-
lished diagnosis of PFAPA. In previous series of PFAPA
patients no familial tendency for periodic fever was men-
tioned [3, 7], but three families with two siblings diagnosed
with PFAPA were recently reported [8, 9]. The FH for re-
current fever was always negative in the healthy children
suggesting that recurrent fever and PFAPA are not fre-
quently found in the general population. Since in 76% of
the FH+ patients the affected relative was a parent or a
sibling, it is very unlikely that a positive FH would have
been missed in the healthy children. In contrast to recur-
rent fever, a FH for rheumatological diseases and psoria-
sis was positive in both PFAPA patients and healthy
children. For rheumatological diseases, we found a trend
of more frequent positive FH in PFAPA patients, but with-
out a significant difference between the two groups. This
observation may suggest that PFAPA patients show an
increased susceptibility to inflammatory diseases, as we
could also describe in an adult patient with both PFAPA
and SpA (Cochard M et al., 2010, data not published).
PFAPA syndrome is one of the auto-inflammatory dis-
eases with recurrent fever like TRAPS, FMF, Hyper-IgD
syndrome, cryopyrin-associated periodic syndrome. A
genetic origin was found for these diseases except for
PFAPA, where no clear aetiology has been found so far
[3]. In most of our patients, the clinical presentation was
clear enough to confirm the diagnosis of PFAPA and gen-
etic testing was performed in only a minority of the pa-
tients. The rate of positive FH was higher for this group of
patients than for the group of clinically diagnosed pa-
tients, showing that despite laboratory exclusion of mono-
genic auto-inflammatory diseases there is still a high
familial predominance for recurrent fever in PFAPA
syndrome.
Our study showed some methodological limitations, be-
cause the diagnosis of PFAPA is based on clinical criteria
and the low prevalence did not allow us to perform the
study prospectively. Furthermore, FH has to rely on the
memory of the person asked and may be incomplete
owing to insufficient knowledge about the diseases pre-
sented by other family members. In our study, the FH was
taken by a limited number of physicians and based on
phone interviews performed in a limited period of time,
ensuring data consistency. As discussed above, the ma-
jority of the affected family members were closely related
to the patient, limiting the risk of inaccurate data. PFAPA
syndrome usually has a benign long-term outcome; thus,
expensive genetic testing in all patients is not justified. As
positive FH is also markedly present in the patients tested
genetically, we believe that the way in which patients were
diagnosed did not bias the results of our study.
Interestingly, three of our PFAPA patients reported
family members with FMF. In these patients, FMF could
be excluded by the clinical presentation, genetic testing
and outcome. The possible predisposition for PFAPA in
the case of a heterozygous mutation of the MEFV gene
has already been studied [10]. In a first paper, MEFV mu-
tations were searched in for six unrelated children with
PFAPA and the results argued against the involvement
of MEFV in PFAPA syndrome [5]. Recently, Kone-Paut
et al. [11] reported the clinical spectrum of 94 MEFV het-
erozygous patients with recurrent fever: 4 patients had
typical features for PFAPA syndrome and 3 of them re-
sponded well to colchicine. The familial predominance of
PFAPA was not related to a specific ethnic background in
our cohort, suggesting that the origin of the family did not
play a role in the susceptibility for the disease. We exam-
ined the profile of both FH+ and FH PFAPA patients, to
evaluate whether they correspond to two different subsets
of PFAPA syndrome. For clinical presentation, gender re-
partition, and age of disease onset, both FH+ and FH
groups were similar; we only found a significant difference
FIG. 2 Frequency of clinical features in FH+ and in FH
PFAPA patients. FH+: patient with a FH of recurrent fever;
FH: patient without FH of recurrent fever.
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for abdominal pain, which is a common symptom in
PFAPA syndrome [12].
With this study, we show for the first time a familial
susceptibility to PFAPA syndrome, suggesting a potential
genetic origin. Therefore, our study reinforces the interest
of further investigations on a genetic marker for PFAPA
syndrome, which would represent a great help for diag-
nosis. Furthermore, if such a marker were available, stu-
dies on the effect of different therapies and on the
long-term outcome could be performed on patients with
a clear diagnosis of PFAPA.
Rheumatology key messages
. PFAPA syndrome is not a sporadic disease.
. A genetic origin for PFAPA syndrome is suspected.
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